Yingxia Li

11PUBLICATIONS
12CO-AUTHORS
Biologically active moleculesMolecular targetsMolecular medicineCheminformatics and quantitative structure-activity relationshipsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 15, 2026
Discovery of Novel Small-Molecule Toll-like Receptor 2 Agonists via a Scaffold Hopping Strategy.

|Jul 17, 2026
Rapid Identification of a Potent, Selective, and Orally Active p300/CBP Bromodomain Inhibitor Bearing an Imidazo[1,2-a]pyridine Scaffold via a Highly Efficient Four-Step Synthesis.

|May 18, 2026
Discovery of CZL-149: A Novel, Highly Potent, and Orally Bioavailable Dual Inhibitor Targeting BET and p300/CBP Bromodomains with Strong Antitumor Efficacy.

|Nov 19, 2025
Discovery of Novel Class of METTL3 Inhibitors with a Pyridin-2(1H)‑one Moiety.

Weihang Zhang, Yuting Huang, Hong Yang

|Oct 13, 2025
Pretargeted Mitochondrial Delivery of Organoarsenicals for Cancer Immunotherapy.

Run Wang, Yuyang Tian, Xuliang Lu

|Sep 24, 2025
Discovery of Potent and Selective FABP4/5 Inhibitors with an Isoquinolone Scaffold as Potential Therapeutics for Inflammation-Related Diseases.

Yulong He, Shunyi Li, Yuqi Chen

Pageof 2

Frequent Collaborators

3 joint publications

Yong Xu

3 joint publications

Zonglong Chen

1 joint publications

Ning Ding

1 joint publications

Lu Zhou